Join our live webinar on October 9. We’ll dive into the critical role of data-driven insights in breaking down the barriers many middle and low-income countries face in accessing lifesaving treatments: https://ow.ly/S7Aw50TqQiJ. Learn how to overcome regulatory, financial, and logistical challenges, ensuring advanced cell and gene therapies are more accessible to underserved populations. Featuring: Jeff Liter, Luminary Therapeutics, Inc Kanya Rajangam, PhD, Senti Biosciences Amicia D. Elliott, Ph.D., Form Bio Kevin Doxzen, Ph.D., Bill & Melinda Gates Foundation Shardha Yeeles, Citeline #TherapyAccess #CGTAccess #GlobalHealth #HealthEquity
About us
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
- Website
-
https://www.citeline.com/
External link for Citeline
- Industry
- Information Services
- Company size
- 501-1,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
New York, New York, US
-
London, City of London, GB
Employees at Citeline
Updates
-
🌟 News. Context. Impact: your weekly premium content roundup. Click "see more" to read individual articles. Check back next week for more! From Scrip—Dupixent Data Could Scratch A Regulatory Itch: https://ow.ly/2BQi50TpBom. Pink Sheet—Easing Market Entry: Japan’s PMDA Allows Approval Filings In English: https://ow.ly/NinV50TpBoo. From Generics Bulletin—Sandoz Feels It Has The Ingredients To Make A Splash In ADCs: https://ow.ly/Fgwb50TpBon. From Medtech Insight—Truvian CEO Confident Blood-Testing Benchtop Could Be ‘Any Place You Go’: https://ow.ly/oQPR50TpBop.
-
Webinar replay available! Commercialising Cell and Gene Therapy bought to you by Citeline & the Indian Pharmaceutical Alliance (IPA). Access it now: https://ow.ly/7ESl50StXWC. This illuminating webinar looks at one of the most active areas of research and investment in the development of medicine, Cell and Gene Therapy (CGT). The promising advancements in CGT present groundbreaking options for treating diseases like cancer, leading to tailored and affordable healthcare solutions for patients. Featuring Shridhar Narayanan - Technical Advisor, IPA , Pooja Rana - Senior Consultant at Citeline, Murali Ramachandra - CEO Aurigene and Rahul Purwar - Founder of ImmunoACT. #CellAndGeneTherapy #CancerTreatment #HealthcareInnovation #MedicalResearch #PharmaceuticalAlliance #BiotechAdvancements #WebinarReplay #IndianPharma
-
Scaling up processes when moving biologics from bench to pilot can be challenging. Join us as experts from Thermo Fisher Scientific share their strategies and insights in this live webinar: https://ow.ly/zpQn50TtF5q. Learn new strategies for maintaining consistent and reproducible growth kinetics, productivity, cell health, and mass transfer.
-
Leverage the power of plain language summaries in your clinical trials. Download the TrialScope Intelligence White Paper today: https://ow.ly/q8qS50TwnUQ.
-
⏰ Last chance to register! 📆 Join us for tomorrow's webinar, your chance to gain a decisive look at the trends that will shape the future of cancer care. https://ow.ly/ZaAF50TfE9k. Register now to stay ahead of the curve and understand the industry-shaping trends that will impact your business. Citeline’s healthcare analysts will dissect the most impactful topics and data from this year’s event. 🗓️ Date: Sep 26, 2024 🕙 Time: 10am NYC | 3pm LDN 📍 Location: Online
-
Citeline reposted this
In a recent webinar sponsored by Vistatec, Lya Rebelo of Citeline gave an overview of the FDA’s guidance on clinical trial diversity action plans, a historical timeline, and an estimate of when we can expect final guidance: https://ow.ly/v7kj50TvnIf.
-
Register now for next week's webinar highlighting Primal Pictures 3D Anatomy & Physiology / Anatomy.tv’s newest module: 3D Real-time Embryology. Fully-interactive 3D models for multiple development stages: https://ow.ly/HTX750TuARm.
-
Our new 3D Real-time Embryology is the raising the bar: previous embryology resources lack translation of the complex 3D morphing, twisting, and development of structures: https://ow.ly/yzqG50TtMbG. Visit Primal Pictures 3D Anatomy & Physiology / Anatomy.tv to schedule a demo or learn about free trial options today.
-
Citeline reposted this
The clinical trial disclosure landscape is changing. Stakeholders demand transparency, and regulations are tightening. Is your organization keeping up? Find out in the first of our clinical trial disclosure maturity model series: https://ow.ly/36si50Tr35I. Featuring Thomas Wicks, Head of Transparency Operations, Citeline.